Caprock Group’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$21.8M Buy
89,367
+3,409
+4% +$794K 0.53% 31
2025
Q4
$17.8M Buy
85,958
+5,565
+7% +$1.1M 0.38% 40
2025
Q3
$14.3M Buy
+80,393
New +$13.8M 0.35% 46
2025
Q1
$12.4M Buy
75,019
+758
+1% +$119K 0.38% 44
2024
Q4
$10.7M Sell
74,261
-667
-0.9% -$103K 0.35% 48
2024
Q3
$12.1M Buy
74,928
+4,941
+7% +$787K 0.44% 34
2024
Q2
$10.2M Buy
69,987
+23,492
+51% +$3.49M 0.42% 39
2024
Q1
$7.36M Sell
46,495
-1,424
-3% -$227K 0.42% 38
2023
Q4
$7.51M Sell
47,919
-133
-0.3% -$20.4K 0.48% 33
2023
Q3
$7.48M Sell
48,052
-288
-0.6% -$47.5K 0.57% 27
2023
Q2
$8M Buy
48,340
+1,132
+2% +$183K 0.59% 26
2023
Q1
$7.32M Buy
47,208
+10,667
+29% +$1.72M 0.57% 28
2022
Q4
$6.46M Sell
36,541
-1,966
-5% -$339K 0.6% 28
2022
Q3
$6.29M Sell
38,507
-73
-0.2% -$12.4K 0.61% 29
2022
Q2
$6.85M Buy
38,580
+1,259
+3% +$224K 0.67% 25
2022
Q1
$6.61M Sell
37,321
-3,767
-9% -$641K 0.62% 29
2021
Q4
$7.03M Sell
41,088
-1,414
-3% -$231K 0.58% 31
2021
Q3
$6.86M Sell
42,502
-1,070
-2% -$183K 0.61% 31
2021
Q2
$7.18M Buy
43,572
+5,086
+13% +$842K 0.65% 30
2021
Q1
$6.33M Sell
38,486
-1,032
-3% -$167K 0.69% 24
2020
Q4
$6.22M Sell
39,518
-2,063
-5% -$304K 0.71% 24
2020
Q3
$6.19M Buy
41,581
+7,107
+21% +$1.05M 0.85% 20
2020
Q2
$4.85M Buy
34,474
+2,661
+8% +$388K 0.73% 23
2020
Q1
$4.17M Buy
31,813
+2,122
+7% +$301K 0.79% 21
2019
Q4
$4.33M Sell
29,691
-2,437
-8% -$331K 0.77% 21
2019
Q3
$4.16M Sell
32,128
-1,403
-4% -$185K 0.81% 21
2019
Q2
$4.67M Sell
33,531
-4,086
-11% -$566K 0.91% 19
2019
Q1
$5.26M Buy
37,617
+1,021
+3% +$137K 1.02% 16
2018
Q4
$4.72M Buy
36,596
+685
+2% +$95.6K 1.09% 14
2018
Q3
$4.96M Sell
35,911
-1,395
-4% -$185K 1.01% 14
2018
Q2
$4.53M Sell
37,306
-2,724
-7% -$340K 0.96% 15
2018
Q1
$5.13M Sell
40,030
-1,966
-5% -$266K 1.1% 13
2017
Q4
$6.12M Sell
41,996
-5,123
-11% -$714K 1.19% 11
2017
Q3
$6.13M Buy
47,119
+424
+0.9% +$56.2K 1.28% 12
2017
Q2
$6.18M Buy
46,695
+3,409
+8% +$435K 1.37% 12
2017
Q1
$5.39M Sell
43,286
-1,364
-3% -$163K 1.27% 17
2016
Q4
$5.14M Sell
44,650
-4,671
-9% -$540K 1.29% 19
2016
Q3
$5.83M Buy
49,321
+7,047
+17% +$855K 1.32% 16
2016
Q2
$5.13M Sell
42,274
-295
-0.7% -$33.5K 1.25% 21
2016
Q1
$4.61M Buy
42,569
+23,550
+124% +$2.44M 1.09% 24
2015
Q4
$1.95M Sell
19,019
-1,667
-8% -$168K 1.12% 22
2015
Q3
$1.93M Buy
20,686
+156
+0.8% +$15.1K 1.37% 18
2015
Q2
$2M Buy
20,530
+13,502
+192% +$1.35M 1.83% 17
2015
Q1
$707K Hold
7,028
0.72% 33
2014
Q4
$735K Buy
+7,028
New +$741K 0.8% 26

Other funds holding JNJ

Caprock Group's JNJ Position: Q1 2026 in Review

Caprock Group increased its Johnson & Johnson (JNJ) stake by 4% in Q1 2026, buying an estimated $794K and bringing the position to 89,367 shares worth $21.8M. The position accounts for 0.53% of the portfolio, ranked #31.

Caprock Group first reported a position in JNJ in Q4 2014 and has held it in 45 quarters since. 4,615 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Caprock Group held 89,367 shares of Johnson & Johnson worth $21.8M as of Q1 2026.
  • Caprock Group bought 3,409 Johnson & Johnson shares in Q1 2026, an estimated $794K.
  • Johnson & Johnson made up 0.53% of Caprock Group's portfolio in Q1 2026, its #31 holding.
  • Caprock Group first reported a position in Johnson & Johnson in Q4 2014 and has held it in 45 quarters since.
  • 4,615 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Caprock Group's 13F filing for Q1 2026, filed 11 May 2026.